TiumBio CEO On Successful Partnerships, Ambitions To Develop The Next Afstyla

Multiple Clinical Assets Progressing

 
• By Jung Won Shin
  
Hun-Taek Kim, CEO of TiumBio
TiumBio Prioritizes Reaching Global, Regional Out-Licensing Deals This Year • Source: TiumBio
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia